Evidence map›Paper›PMID 28455578›Full record

ReviewDer Urologe. Ausg. A2017

[Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients : Update 2017 of the interdisciplinary AWMF S3 guideline].

J Kranz, S Schmidt, C Lebert, L Schneidewind, W Vahlensieck, U Sester, R Fünfstück, S Helbig, W Hofmann, E Hummers and 7 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Nitrofurantoin: what is the evidence for current UK guidance?The Journal of antimicrobial chemotherapy · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 14 institutions in 1 country.

J KranzKlinik für Urologie und Kinderurologie, St. Antonius-Hospital, Akademisches Lehrkrankenhaus der RWTH Aachen, Dechant-Deckers-Straße 8, 52249, Eschweiler, Deutschland. jennifer.kranz@sah-eschweiler.de.
S SchmidtUroEvidence@Deutsche Gesellschaft für Urologie, Berlin, Deutschland.
C LebertApotheke, Klinikum Nürnberg, Nürnberg, Deutschland.
L SchneidewindUroEvidence@Deutsche Gesellschaft für Urologie, Berlin, Deutschland.
W VahlensieckFachklinik für Urologie, Kurparkklinik, Bad Nauheim, Deutschland.
U SesterInnere Medizin IV, Universitätsklinikum des Saarlandes, Bad Homburg, Deutschland.
R FünfstückKlinik für Innere Medizin I, Sophien- und Hufeland-Klinikum GmbH, Weimar, Deutschland.
S HelbigKlinische Infektiologie, Universitätsklinikum Carl Gustav Carus, Dresden, Deutschland.
W HofmannDepartment Klinische Chemie, Städtisches Klinikum München, München, Deutschland.
E HummersInstitut für Allgemeinmedizin, Universitätsmedizin Göttingen, Göttingen, Deutschland.
M KunzeKlinik für Frauenheilkunde, Universitätsklinikum Freiburg, Freiburg, Deutschland.
E KniehlAbteilung für Mikrobiologie und Krankenhaushygiene, Städtisches Klinikum Karlsruhe, Karlsruhe, Deutschland.
K NaberUrologische Klinik, Technische Universität, München, Deutschland.
F MandrakaKlinische Infektiologie, Labor Dr. Wisplinghoff, Köln, Deutschland.
B Mündner-HensenICA-Deutschland e.V., Förderverein Interstitielle Zystitis (ICA), Euskirchen, Deutschland.
G SchmiemannInstitut für Public Health und Pflegeforschung, Versorgungsforschung, Universität Bremen, Bremen, Deutschland.
F M E WagenlehnerKlinik und Poliklinik für Urologie, Kinderurologie und Andrologie, Universitätsklinikum Giessen und Marburg GmbH, Justus-Liebig-Universität Giessen, Giessen, Deutschland.
Universitätsklinikum des Saarlandes · DEDeutsche Gesellschaft für Urologie · DEKlinik für Frauenheilkunde · DELaboratory Dr. Wisplinghoff · DEMünchen Klinik · DENuremberg Hospital · DESankt-Antonius-Hospital Eschweiler · DESophien-und Hufeland Klinikum · DEStädtisches Klinikum Karlsruhe · DETechnical University of Munich · DEUniversitätsmedizin Göttingen · DEUniversity Hospital Carl Gustav Carus · DEUniversity of Bremen · DEUniversity of Giessen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUpdate of the 2010 published evidence-based S3 guideline on epidemiology, diagnostics, therapy and management of uncomplicated, bacterial, outpatient-acquired urinary tract infections in adult patients. The guideline contains current evidence for the rational use of antimicrobial substances, avoidance of inappropriate use of certain antibiotic classes and development of resistance. METHODOLOGY: The update was created under the leadership of the German Association of Urology (DGU). A systematic literature search was conducted for the period 01 January 2008 to 31 December 2015. International guidelines have also been taken into account. Evidence level and risk of bias were used for quality review.

resultsUpdated information on bacterial susceptibility, success, collateral damage and safety of first- and second-line antibiotics was given. For the treatment of uncomplicated cystitis the first line antibiotics are fosfomycin trometamol, nitrofurantoin, nitroxoline, pivmecillinam, trimethoprim (with consideration of the local resistance rates). Fluoroquinolones and cephalosporins should not be used as first choice antibiotics. In the case of uncomplicated pyelonephritis of mild to moderate forms, preferably cefpodoxime, ceftibuten, ciprofloxacin or levofloxacin should be used as oral antibiotics.

conclusionThe updated German S3 guideline provides comprehensive evidence- and consensus-based recommendations on epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients. Antibiotic stewardship aspects have significantly influenced the therapeutic recommendations. A broad implementation in all clinical practice settings is necessary to ensure a foresighted antibiotic policy and thus t improve clinical care.

Indexed as

Practice Guidelines as TopicAllergy and ImmunologyAnti-Bacterial AgentsBacterial InfectionsBacteriuriaDose-Response Relationship, DrugDrug Administration ScheduleEvidence-Based MedicineGermanyHumansPrevalenceRisk FactorsSecondary PreventionTherapeuticsUrologyAnti-Bacterial AgentsAntibiotic resistanceAWMF S3-guidelinePrevention antibiotic stewardshipTreatment recommendationsUrinary tract infections

Identifiers

PMID28455578
OpenAlexW2989881887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.